Oncopeptalks

Oncopeptides is stepping into one of oncology’s toughest challenges – glioblastoma (malignant brain tumor) – a topic we explore in the latest episode of Oncopeptalks.

In this conversation, CEO Sofia Heigis, CMO Stefan Norin, and COO Eva Nordström share their insights on why Oncopeptides’ PDC platform could make a difference where so many others have failed.

Podcast in Swedish, follow this link for transcripts in Swedish and English:
https://oncopeptalks.vercel.app/

The team at Oncopeptides reflects on this year´s presence at the European Hematology Association (EHA) Congress.

Joining in on the discussion was:

Sofia Heigis, CEO
Lina Rörby Franzen, Global Marketing & Business Excellence Director
Bruno Bolognese, Country Manager – Italy
Christina Bando, Country Manager – Spain
Heiko Singer, Medical Affairs – DACH region

For transcript in English and Swedish, please visit https://oncopeptalks.vercel.app/

In this premiere episode of Oncopeptalks in a brand-new podcast format, we sit down with Sofia Heigis, CEO of Oncopeptides, to discuss the company’s core mission, and what it actually takes to market an advanced cancer treatment in Europe.

We’re going back to basics:

*What is the company’s flagship drug, and which patients is it intended for?
*Why has Oncopeptides launched specifically in Germany, Austria, Spain, and Italy, and not the rest of Europe?
*How long does it really take before a doctor feels ready to prescribe a new treatment to their most critically ill patients?

This episode is for anyone who wants an inside look at Oncopeptides, whether you are a new listener or have followed the company for years. The content is in Swedish only.

In the latest, and “final”, Oncopeptalks, Sofia covers, among other things, congress season, and David provides some updates from the communications side – including that Oncopeptalks will take on a new shape in the future.

In the latest episode of Oncopeptalks, Sofia Heigis talks more about recent initiatives to strengthen access to real‑world data in the company’s key markets. She also answers a number of questions from investors on everything from the sales landscape in Germany and Italy to the recently completed share issue.

The video is available in Swedish, with Swedish or English subtitles.